Variant curation and interpretation in hereditary cancer genes: An institutional experience in Latin America
Molecular Genetics & Genomic Medicine · 2023-05 · 11 (5)
DOI: 10.1002/mgg3.2141 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Genetics & Genomic Medicine, online erschienen am 10.03.2023. Verfasst von María Carolina Manotas und 2 weiteren Autor:innen. Beteiligte Einrichtung: Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia. Hauptthemen laut MEDLINE: Genetic Variation, Neoplastic Syndromes, Hereditary. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Variant curation refers to the application of evidence‐based methods for the interpretation of genetic variants. Significant variability in this process among laboratories affects clinical practice. For admixed Hispanic/Latino populations, underrepresented in genomic databases, the interpretation of genetic variants for cancer risk is challenging.
Methods
We retrospectively evaluated 601 sequence variants detected in patients participating in the largest Institutional Hereditary Cancer Program in Colombia. VarSome and PathoMAN were used for automated curation, and ACMG/AMP and Sherloc criteria were applied for manual curation.
Results
Regarding the automated curation, 11% of the variants (64/601) were reclassified, 59% (354/601) had no changes in its interpretation, and the other 30% (183/601) presented conflicting interpretations. With respect to manual curation, of the 183 variants with conflicting interpretations, 17% ( N = 31) were reclassified, 66% ( N = 120) had no changes in their initial interpretation, and 17% ( N = 32) remained with conflicting interpretation status. Overall, 91% of the VUS were downgraded and 9% were upgraded.
Conclusions
Most VUS were reclassified as benign/likely benign. Since false‐positive and ‐negative results can be obtained with automated tools, manual curation should also be used as a complement. Our results contribute to improving cancer risk assessment and management for a broad range of hereditary cancer syndromes in Hispanic/Latino populations.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medical Subdirection, Instituto Nacional de Cancerología, Bogotá, Colombia.
- Subdirection of Research, Instituto Nacional de Cancerología, Bogotá, Colombia.
ORCID-Profile: María Carolina Manotas, Ana Lucia Rivera, María Carolina Sanabria-Salas
Zitieren
APA
Manotas, M. C., Rivera, A. L., & Sanabria-Salas, M. C. (2023). Variant curation and interpretation in hereditary cancer genes: An institutional experience in Latin America. Molecular Genetics & Genomic Medicine, 11(5). https://doi.org/10.1002/mgg3.2141
Vancouver
Manotas MC, Rivera AL, Sanabria-Salas MC. Variant curation and interpretation in hereditary cancer genes: An institutional experience in Latin America. Molecular Genetics & Genomic Medicine. 2023;11(5). doi:10.1002/mgg3.2141
BibTeX
@article{Manotas2023,
author = {Manotas, María Carolina and Rivera, Ana Lucia and Sanabria-Salas, María Carolina},
title = {Variant curation and interpretation in hereditary cancer genes: An institutional experience in Latin America},
journal = {Molecular Genetics & Genomic Medicine},
year = {2023},
volume = {11},
number = {5},
doi = {10.1002/mgg3.2141}
}
EUVIMED